Dec 22, 2025
What’s Going On With Firefly Aerospace Stock Monday?

Firefly Aerospace Inc. (NASDAQ:FLY) shares are trading higher Monday amid broader strength in space-related stocks. The company also announced it will join the Russell 2000 and Russell 3000 indexes. Firefly Aerospace shares are climbing with conviction. What’s behind FLY gains? What…

Dec 22, 2025
Gilead Sciences Bets On Weekly Pill To Tackle Genital Herpes

Gilead Sciences, Inc. (NASDAQ:GILD) and Assembly Biosciences, Inc. (NASDAQ:ASMB) announced on Monday that Gilead has exercised its combined option to exclusively license Assembly Bio’s herpes simplex virus (HSV) helicase-primase inhibitor programs, including long-acting investigational candidates ABI-1179 and ABI-5366 for recurrent…

Dec 22, 2025
Carnival Quietly Puts Pricing Fears To Rest With Standout Quarter

Carnival Corporation (NYSE:CCL) stock rose Monday after the cruise operator reported record fourth-quarter profit and cash flow. Following the results, Goldman Sachs analyst Lizzie Dove raised her price forecast to $34 from $31 and reiterated a Buy rating. Earnings Snapshot…

Dec 22, 2025
Rocket Lab Mach 70: Why The Stock Is At All-Time Highs

Rocket Lab Corp. (NASDAQ:RKLB) has transitioned from a promising space startup to a dominant aerospace powerhouse—and its stock reflects the growth.  RKLB stock is climbing. See the chart and price action here.  Last week, the company secured its largest-ever contract—an…

Dec 22, 2025
What’s Going On With Stanley Black & Decker Shares Monday?

Stanley Black & Decker, Inc. (NYSE:SWK) shares are trading higher Monday after the company announced it will sell its Consolidated Aerospace Manufacturing business to Howmet Aerospace. Stanley Black & Decker shares are powering higher. What’s driving SWK stock higher? What To…

Dec 22, 2025
Vale Stock Is Surging Monday: What’s Driving The Action?

Vale SA (NYSE:VALE) shares are rallying Monday afternoon amid a broader surge in precious metals stocks driven by fiscal deficits in major economies including the U.S., U.K. and China. Here’s what investors need to know. Vale shares are powering higher.…

Dec 22, 2025
Why Wall Street Is Watching Immutep’s Experimental Autoimmune Treatment Closely

Immutep Limited (NASDAQ:IMMP) on Monday shared an update from the placebo-controlled, double-blind first-in-human Phase I study in healthy participants evaluating IMP761, a first-in-class LAG-3 agonist antibody for autoimmune diseases. The single-ascending dose escalation portion of the trial completed the 2.5…